Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer cell"
DOI: 10.1016/j.ccell.2018.03.023
Abstract: CDK4/6 inhibitors are among a new generation of therapeutics. Building upon the striking success of the combination of CDK4/6 inhibitors and the hormone receptor antagonist letrozole in breast cancer, many other combinations have recently entered…
read more here.
Keywords:
may simple;
inhibitors mechanism;
cdk4;
cdk4 inhibitors ... See more keywords